The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
NCT ID: NCT07144592
Last Updated: 2025-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
60 participants
INTERVENTIONAL
2025-01-01
2025-10-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital. Participants will be randomly assigned to an experimental group (n=30) and a control group (n=30).
The experimental group will receive one individual solution-focused therapy session per week for six weeks. The control group will receive usual care only. Data will be collected using a Personal Information Form, the Psychosocial Adjustment Scale (PSSAS), and the Medication Adherence Scale (MARS).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Psychosocial Skills Focused Group Psychoeducation in Schizophrenia Patients
NCT06872424
Salutogenic Approach Based Interview With People With Schizophrenia
NCT04740944
The Effect of Social Skills Intervention on Praxis and Social Functioning in Individuals With Schizophrenia
NCT05901922
The Effectiveness of Psychosocial Skills Training Applied to Individuals Diagnosed With Schizophrenia
NCT07017881
The Effect of Salutogenic-based Interviewing on Subjective Recovery and Quality of Life in Schizophrenia
NCT06820580
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Schizophrenia is a chronic psychiatric disorder that significantly affects thought, emotion, and behavior, often limiting social functioning, treatment adherence, and integration into daily life. There is an increasing need for person-centered, empowering, and brief intervention models in psychiatric nursing. This study aims to determine the effects of a solution-focused approach (SFA)-based individual intervention on psychosocial adjustment and treatment adherence in individuals with schizophrenia.
Study Design:
This research will use a pretest-posttest randomized controlled experimental design with a control group.
Study Population:
The study will include 60 individuals diagnosed with schizophrenia according to DSM-5 diagnostic criteria, considered clinically stable, and registered at a Community Mental Health Center affiliated with a university hospital in Türkiye. Participants will be randomly assigned to an experimental group (n=30) or a control group (n=30) using computer-assisted randomization.
Intervention:
Experimental Group: Participants will receive individual solution-focused therapy sessions once per week for six consecutive weeks. The sessions will emphasize individual strengths, recall positive coping experiences, support future goal setting, and provide guidance on repeating effective solutions.
Control Group: Participants will receive no additional intervention beyond usual care.
Outcome Measures:
Data will be collected with the following instruments:
Personal Information Form
Psychosocial Adjustment Scale (PSSAS)
Medication Adherence Scale (MARS)
Statistical Analyses:
Planned analyses will include independent samples t-tests, paired t-tests, and ANCOVA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental group (Solution-Focused Approach Program)
A 6-week solution-focused approach program will be applied to the experimental group.
solution-oriented approach program
The solution-focused nursing intervention applied to the experimental group in the study was planned as individual sessions, consisting of one session per week, lasting a total of six weeks. The interventions were based on the principles of solution-focused brief therapy, focusing on the individual's strengths, past coping experiences, and current resources. The interviews aimed to identify exceptions, build positive future expectations, set small but achievable goals, strengthen hope, and increase the individual's ability to utilize their internal resources. Each session used structured open-ended questions, scaling techniques, and future-oriented solution scenarios to support the individual's psychosocial adjustment and motivation for treatment.
control group (No Intervention: Usual Care at Community Mental Health Center)
No intervention will be applied to the control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
solution-oriented approach program
The solution-focused nursing intervention applied to the experimental group in the study was planned as individual sessions, consisting of one session per week, lasting a total of six weeks. The interventions were based on the principles of solution-focused brief therapy, focusing on the individual's strengths, past coping experiences, and current resources. The interviews aimed to identify exceptions, build positive future expectations, set small but achievable goals, strengthen hope, and increase the individual's ability to utilize their internal resources. Each session used structured open-ended questions, scaling techniques, and future-oriented solution scenarios to support the individual's psychosocial adjustment and motivation for treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Being between 18 and 65 years of age,
Being literate and verbally communicative,
Being clinically stable (not exhibiting symptoms of acute psychosis),
Being registered with a Community Mental Health Center (CMHC) and receiving regular services,
Being cognitively competent enough to participate in individual interviews during the research process,
Being an individual currently receiving psychiatric treatment and taking medication,
Agreeing to participate voluntarily in the study and signing a written informed consent form.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Muş Alparslan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatih Sahin
doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Community Mental Health Center
Muş, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
167678
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.